130 related articles for article (PubMed ID: 1994590)
21. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
22. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
Exley T; Parti S; Barwick S; Meager A
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
[TBL] [Abstract][Full Text] [Related]
26. Relativity of an antigenic homology between human interferon-alpha 1 and interferon-alpha 2c.
Csabayová M; Kontseková E; Kontsek P
Immunol Invest; 1995 Aug; 24(5):787-93. PubMed ID: 8543342
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells.
Fish EN; Banerjee K; Stebbing N
Biochem Biophys Res Commun; 1983 Apr; 112(2):537-46. PubMed ID: 6303322
[TBL] [Abstract][Full Text] [Related]
28. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
[TBL] [Abstract][Full Text] [Related]
29. Two monoclonal antibodies distinguish between human recombinant interferon-alpha 5s produced by Escherichia coli and by mouse cells.
Tsukui K; Fukunaga R; Nagata S; Ito K
Microbiol Immunol; 1986; 30(12):1271-9. PubMed ID: 2437432
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
Antonelli G; Currenti M; Turriziani O; Dianzani F
J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
[TBL] [Abstract][Full Text] [Related]
31. Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells.
Capobianchi MR; Mattana P; Mercuri F; Conciatori G; Ameglio F; Ankel H; Dianzani F
J Interferon Res; 1992 Dec; 12(6):431-8. PubMed ID: 1289411
[TBL] [Abstract][Full Text] [Related]
32. Production of monoclonal antibodies to human IFN-alpha and their use for analysis of the antigenic composition of various natural interferons.
Adolf GR; Bodo G; Swetly P
J Cell Physiol Suppl; 1982; 2():61-8. PubMed ID: 6302110
[TBL] [Abstract][Full Text] [Related]
33. [Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV].
Dianzani F; Capobianchi MR; De Marco F; Di Marco P; Gentile M; Antonelli G; Amicucci P; Cefaro A; Ruggiero V; Turriziani O
Ann Ig; 1989; 1(3-4):647-60. PubMed ID: 2483637
[TBL] [Abstract][Full Text] [Related]
34. Human interferon omega 1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein.
Adolf GR; Frühbeis B; Hauptmann R; Kalsner I; Maurer-Fogy I; Ostermann E; Patzelt E; Schwendenwein R; Sommergruber W; Zöphel A
Biochim Biophys Acta; 1991 Jun; 1089(2):167-74. PubMed ID: 1647209
[TBL] [Abstract][Full Text] [Related]
35. Antigenic link between human interferons-alpha and -beta: the common epitope 1.
Kontsek P; Borecký L; Kontseková E; Novák M; Krchnák V
J Interferon Res; 1990 Apr; 10(2):119-28. PubMed ID: 1692865
[TBL] [Abstract][Full Text] [Related]
36. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
37. Cross-species antiviral and antiproliferative activity of human interferon-omega.
Kubes M; Fuchsberger N; Kontsek P
J Interferon Res; 1994 Apr; 14(2):57-9. PubMed ID: 8077766
[TBL] [Abstract][Full Text] [Related]
38. Interferon-omega: Current status in clinical applications.
Li SF; Zhao FR; Shao JJ; Xie YL; Chang HY; Zhang YG
Int Immunopharmacol; 2017 Nov; 52():253-260. PubMed ID: 28957693
[TBL] [Abstract][Full Text] [Related]
39. Human interferon and cell growth inhibition. VII. Reversibility of interferon activities.
Dahl H
J Interferon Res; 1983; 3(4):387-93. PubMed ID: 6323590
[TBL] [Abstract][Full Text] [Related]
40. Antiviral and antiproliferative activities of human leukocyte interferon potentiated by cimetidine in vitro.
Hirai N; Hill NO; Motoo Y; Osther K
J Interferon Res; 1985; 5(3):375-82. PubMed ID: 2997335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
